Skip to main content
Year archive

ACRUX LIMITED — 2011 filings

All 41 regulatory filings released by ACRUX LIMITED (ACR) in 2011, sourced directly from the official regulator.

41 Filings
2011 Period
2011 filings (41)
Filing Released Lang
Orion manufacturing facility update 1 page 23.2KB
Regulatory Filings
2011-11-30 English
Orion manufacturing facility, Finland 1 page 23.2KB
Regulatory Filings
2011-11-23 English
2011 AGM Chairman`s Address 1 page 16.3KB
AGM Information
2011-11-22 English
2011 AGM CEO Presentation 15 pages 1.4MB
Regulatory Filings
2011-11-22 English
2011 AGM Results of Meeting 1 page 57.6KB
Declaration of Voting Results & Voting Rights Announcements
2011-11-22 English
Change of Director`s Interest Notice 2 pages 79.2KB
Director's Dealing
2011-11-03 English
2026 patent for Axiron granted by Australian patent office 2 pages 25.3KB
Regulatory Filings
2011-11-02 English
2011 Annual Report 72 pages 1.3MB
Annual Report
2011-10-20 English
2011 AGM Notice and Proxy Form 7 pages 218.6KB
Regulatory Filings
2011-10-20 English
Marketing authorisation for Recuvyra granted in Europe 2 pages 19.5KB
Regulatory Filings
2011-10-12 English
Market Update 1 page 23.3KB
Capital/Financing Update
2011-09-27 English
SandP Indices Announces September Quarterly Rebalance 3 pages 100.7KB
Regulatory Filings
2011-09-08 English
Change in substantial holding 4 pages 97.5KB
Regulatory Filings
2011-09-07 English
SandP Indices Announces September SP/ASX 200 Rebalance 1
Regulatory Filings
2011-09-01 English
Acrux not required to file quarterly cash flow reports 1
Regulatory Filings
2011-08-30 English
Acrux founder Barrie Finnin retires from the board 1
Board/Management Information
2011-08-30 English
Final Director`s Interest Notice 2 pages 73.8KB
Director's Dealing
2011-08-30 English
Change of Director`s Interest Notice 2 pages 78.9KB
Director's Dealing
2011-08-30 English
Appendix 4E and Financial Report for the year ended 30 June 71 pages 3.9MB
Regulatory Filings
2011-08-22 English
Acrux Reports Full Year Profit of $57 Million 4 pages 50.5KB
Annual Report
2011-08-22 English
2010/11 Financial Results 4 pages 100.5KB
Earnings Release
2011-08-22 English
Eli Lilly Report to Acrux Investment Community 17 pages 2.4MB
Investor Presentation
2011-08-22 English
Change in substantial holding 4 pages 93.9KB
Regulatory Filings
2011-08-01 English
Appendix 4C - Quarterly Cash Flow Report 5 pages 188.7KB
Interim / Quarterly Report
2011-07-28 English
Change in substantial holding 4 pages 94.5KB
Regulatory Filings
2011-07-17 English
Eli Lilly provides feedback on initial uptake of Axiron 4 pages 548.8KB
Capital/Financing Update
2011-06-30 English
Acrux receives marketing approval for Ellavie in Sweden 2 pages 131.3KB
Regulatory Filings
2011-05-26 English
Appendix 3B 7 pages 272.6KB
Share Issue/Capital Change
2011-05-11 English
Positive European opinion for first animal health product 2 pages 103.7KB
Regulatory Filings
2011-05-09 English
Appendix 4C - Quarterly Cash Flow Report 5 pages 188.5KB
Interim / Quarterly Report
2011-04-28 English
Appendix 3B 7 pages 273.5KB
Share Issue/Capital Change
2011-04-06 English
Axiron Launched by Eli Lilly in the United States 2 pages 55.4KB
Regulatory Filings
2011-03-30 English
Acrux Declares First Dividend of 60 cents per share 3 pages 50.2KB
Notice of Dividend Amount
2011-03-23 English
Appendix 3B 7 pages 273.2KB
Share Issue/Capital Change
2011-03-15 English
Half Year Accounts and Appendix 4D 22 pages 370.7KB
Regulatory Filings
2011-02-23 English
Acrux Files Half Year Results 4 pages 54.5KB
Interim / Quarterly Report
2011-02-23 English
Appendix 3B 7 pages 273.2KB
Share Issue/Capital Change
2011-02-14 English
Ceasing to be a substantial holder 3 pages 64.9KB
Regulatory Filings
2011-02-03 English
Appendix 4C - Quarterly Cash Flow Report 5 pages 188.3KB
Interim / Quarterly Report
2011-01-30 English
Appendix 3B 7 pages 273.2KB
Share Issue/Capital Change
2011-01-20 English
Regulatory update on animal health product 1 page 2
Regulatory Filings
2011-01-12 English